Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds
Weimin Qiu, Hui Liu, Yijun Liu, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 1091-1140
Open Access | Times Cited: 12

Showing 12 citing articles:

Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Enjie Liu, Yao Zhang, Jian–Zhi Wang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Screening Techniques for Drug Discovery in Alzheimer’s Disease
Sandra Maniam, Subashani Maniam
ACS Omega (2024) Vol. 9, Iss. 6, pp. 6059-6073
Open Access | Times Cited: 10
Mesenchymal stem cell-derived extracellular vesicles: A novel promising neuroprotective agent for Alzheimer's disease
Jun Chang, Zihang Feng, Yujiao Li, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116064-116064
Closed Access | Times Cited: 10
Enantiomer-Dependent Supramolecular Immunosuppressive Modulation for Tissue Reconstruction
Zhixiang Mu, Tianxi Shen, Hui Deng, et al.
ACS Nano (2024) Vol. 18, Iss. 6, pp. 5051-5067
Closed Access | Times Cited: 8
Navigating the Maze of Alzheimer’s disease by exploring BACE1: Discovery, current scenario, and future prospects
Faiza Iram, Mohammad Shahid, Jaoud Ansari, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102342-102342
Closed Access | Times Cited: 7
Design, synthesis, and bio-evaluation of C1-aryl galantamine derivatives
Shuishu Wang, Wan-Sheng Ji, Longjiang Chen, et al.
Fitoterapia (2025) Vol. 183, pp. 106535-106535
Closed Access
Design, Synthesis, and Bio-Evaluation of C2-Aryl Galantamine Derivatives
Shuishu Wang, Wan-Sheng Ji, Lianhai Shan, et al.
(2025)
Closed Access
Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer’s Disease: A Critical Review of New and Old Little Regarded Findings
Anna Atlante, Daniela Valenti
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15951-15951
Open Access | Times Cited: 9
Alzheimer's Disease: Status of Low‐Dimensional Nanotherapeutic Materials
Dongqing Huang, Wang Liao, Jun Li, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 4
Closed Access | Times Cited: 6
Strategies for measuring concentrations and forms of amyloid-β peptides
Hangyu Shen, Keyin Liu, Fangong Kong, et al.
Biosensors and Bioelectronics (2024) Vol. 259, pp. 116405-116405
Closed Access | Times Cited: 1
Can Targeted Protein Degradation Technology Provide a Potential Breakthrough in the Development of Anti-AD Drugs?
Baichen Xiong, Zuoaoyun Song, Leyan Wang, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 19, pp. 3434-3436
Closed Access | Times Cited: 1
A Ru3+-Functionalized-NMOF Nanozyme as an Inhibitor and Disaggregater for β-Amyloid Aggregates
Luo Wan-chun, Lina Bao, Yufan Zhang, et al.
Journal of Materials Chemistry B (2024)
Closed Access | Times Cited: 1
Design of Self-Assembled Nanoparticles as a Potent Inhibitor and Fluorescent Probe for β-Amyloid Fibrillization
Ying Wang, Wei Liu, Xiaoyan Dong, et al.
Langmuir (2023) Vol. 39, Iss. 36, pp. 12576-12589
Closed Access | Times Cited: 3
Page 1

Scroll to top